Medication info
Irbesartan 300 mg Tablets

Irbesartan 300 mg Tablets

Prescription medicationTabletOral
Ingredient · strength
Irbesartan›300mg / 1 tablet
Manufacturer / importer
Myungin Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201404443 · Approved 2014.09.29 · Insurance code 651904050

Summary

Main use
Treatment of essential hypertension and nephropathy in patients with type 2 diabetes and hypertension
Who takes it
Adults
Adult dose
This drug may be taken with or without food. 1. Essential hypertension Adults: Administer irbesartan orally at a dose of 150 mg once daily; the dose may be increased to 300 mg if the effect is insufficient. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily, but 75 mg may be considered in special cases (e.g., at the start of treatment, in patients receiving hemodialysis, or in elderly patients aged 75 years and older). If blood pressure is not adequately controlled with monotherapy, another antihypertensive agent may be administered concomitantly. The effect is enhanced particularly when this drug is administered with a low dose of a diuretic (e.g., hydrochlorothiazide). 2. Nephropathy in patients with type 2 diabetes and hypertension Adults: It is recommended to initiate oral treatment with 150 mg of this drug once daily and increase the dose to 300 mg for maintenance. Another antihypertensive agent may be administered concomitantly, if necessary, to achieve the target blood pressure. ○ Elderly patients Dose adjustment is generally not required; however, a starting dose of 75 mg should be considered for patients aged 75 years and older. ○ Patients with renal impairment Dose adjustment is generally not required; however, a starting dose of 75 mg should be considered for patients receiving hemodialysis. ○ Patients with hepatic impairment Dose adjustment is generally not necessary in patients with mild to moderate hepatic impairment, but it is recommended not to exceed 150 mg per day. However, there is no clinical experience in patients with severe hepatic impairment.

Ingredients

Manufacturer
Myungin Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and nephropathy in patients with type 2 diabetes and hypertension

  • Essential hypertension
  • hypertension
  • kidney disease in patients with type 2 diabetes.
View approved original text

This medication is used to control blood pressure in patients with essential hypertension. It also helps protect kidney function and slow the progression of kidney disease in patients with hypertension and type 2 diabetes. Therefore, it plays an important role in preventing complications related to hypertension and improving overall vascular health in patients.

How to take

Adult dose

This drug may be taken with or without food. 1. Essential hypertension Adults: Administer irbesartan orally at a dose of 150 mg once daily; the dose may be increased to 300 mg if the effect is insufficient. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily, but 75 mg may be considered in special cases (e.g., at the start of treatment, in patients receiving hemodialysis, or in elderly patients aged 75 years and older). If blood pressure is not adequately controlled with monotherapy, another antihypertensive agent may be administered concomitantly. The effect is enhanced particularly when this drug is administered with a low dose of a diuretic (e.g., hydrochlorothiazide). 2. Nephropathy in patients with type 2 diabetes and hypertension Adults: It is recommended to initiate oral treatment with 150 mg of this drug once daily and increase the dose to 300 mg for maintenance. Another antihypertensive agent may be administered concomitantly, if necessary, to achieve the target blood pressure. ○ Elderly patients Dose adjustment is generally not required; however, a starting dose of 75 mg should be considered for patients aged 75 years and older. ○ Patients with renal impairment Dose adjustment is generally not required; however, a starting dose of 75 mg should be considered for patients receiving hemodialysis. ○ Patients with hepatic impairment Dose adjustment is generally not necessary in patients with mild to moderate hepatic impairment, but it is recommended not to exceed 150 mg per day. However, there is no clinical experience in patients with severe hepatic impairment.

Precautions

This medication should not be used during pregnancy. It may cause serious harm to the fetus and newborn, so it should be discontinued immediately if pregnancy is confirmed. Patients with an allergy to this medicine, severe liver impairment, hereditary angioedema, or women who are pregnant or breastfeeding should not take this medicine. Additionally, this medication should not be used in patients with diabetes or severe kidney dysfunction, or diabetic nephropathy who are on ACE inhibitors. Patients who are elderly or have high serum potassium levels or impaired liver function should use this medication cautiously, and liver or kidney function should be monitored periodically. Patients with heart valve disease or cerebrovascular disease should also be cautious when taking this medication due to the risk of excessively low blood pressure. This medicine lowers blood pressure, so if there is low blood volume or sodium deficiency, symptoms of hypotension may occur; therefore, it is important to check the condition before taking this medication. Regular monitoring of blood pressure, kidney function, and electrolyte levels is important while taking this medication. If symptoms such as swelling of the face, lips, tongue, or difficulty breathing occur during treatment, it is essential to consult a doctor immediately. Side effects may include dizziness, fatigue, headache, dyspepsia, diarrhea, but most are mild and temporary. This medication may interact with other blood pressure medications, diuretics, and potassium supplements, so it is essential to consult with a doctor or pharmacist regarding other medications being taken. Particular caution is needed when taking this with lithium or non-steroidal anti-inflammatory drugs (NSAIDs). Additionally, some diabetes medications may affect blood sugar control when taken concurrently, so it is important to monitor blood sugar levels. This medication is not recommended for breastfeeding women; if it must be taken, breastfeeding should be discontinued. Overdosage may cause hypotension or heart rhythm abnormalities, so taking the correct dosage is important, and any unusual symptoms should be reported to medical personnel immediately. Safety in children or adolescents has not been established, so it's best not to use it. Caution is needed when driving or operating machinery as dizziness or fatigue may occur.

Side effects

  • Respiratory infection
  • headache
  • musculoskeletal pain
  • dizziness
  • fatigue
  • diarrhea
  • cough
  • nausea
  • vomiting
  • musculoskeletal injury
Show 109 more
  • chest pain
  • indigestion
  • heartburn
  • edema
  • abdominal pain
  • rash
  • tachycardia
  • anxiety
  • irritability
  • upper urinary tract infection
  • fever
  • chills
  • facial swelling
  • arm swelling
  • flushing
  • hypertension
  • heart murmurs
  • myocardial infarction
  • angina pectoris
  • arrhythmia
  • conduction abnormalities
  • cardiac arrest
  • heart failure
  • hypertensive crisis
  • itching
  • dermatitis
  • petechiae
  • erythema
  • urticaria
  • sexual dysfunction
  • changes in sexual function
  • gout
  • constipation
  • oral lesions
  • gastritis
  • abdominal distension
  • limb edema
  • muscle stiffness
  • arthritis
  • myalgia
  • joint stiffness
  • bursitis
  • muscle weakness
  • sleep disorders
  • paralysis
  • hypersomnia
  • mood disorders
  • depression
  • sensory abnormalities
  • tremor
  • transient ischemia
  • cerebrovascular accident
  • abnormal urination
  • prostate abnormalities
  • nosebleed
  • bronchitis
  • congestion
  • pulmonary congestion
  • dyspnea
  • wheezing
  • visual impairment
  • auditory abnormalities
  • otitis
  • otalgia
  • conjunctivitis
  • eyelid abnormalities
  • ear abnormalities
  • dizziness
  • orthostatic vertigo
  • orthostatic hypotension
  • increased plasma creatine kinase
  • hyperkalemia
  • hypersensitivity reactions
  • rash
  • urticaria
  • angioedema
  • anaphylactic shock
  • anaphylactic reaction
  • cough
  • intestinal vascular edema
  • weakness
  • diarrhea
  • indigestion
  • nausea
  • tinnitus
  • myalgia
  • increased plasma creatine kinase
  • arthralgia
  • tachycardia
  • hepatitis
  • liver function abnormalities
  • renal insufficiency
  • psoriasis
  • photosensitivity
  • anemia
  • thrombocytopenia
  • hypoglycemia
  • angioedema
  • shock
  • syncope
  • loss of consciousness
  • renal failure
  • liver dysfunction
  • jaundice
  • hypoglycemia
  • rhabdomyolysis
  • hypotension
  • tachycardia
  • bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture and should be stored in a tightly closed container. Also, it should be kept in a cool, dry place below 30 degrees Celsius to maintain its effectiveness.

Appearance and packaging

Appearance

White oval film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.